The governor joined Mayo Clinic President and CEO Dr. Kent Thielen Thursday to announce the launch of the first carbon ion ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly developed antibody can restore immune responses in mice. Pancreatic cancer remains ...

GT Biopharma submitted an IND application for GTB-5550 TriKE for solid tumors. Phase 1 trial planned for 2026.

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

Baptist Hospital's new cancer center in Southeast Texas offers advanced HyperArc radiation technology, drastically cutting ...

Though the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal ...

A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical study.

The ACS estimates that 626,140 people in the U.S. will die from cancer in 2026, amounting to about 1,720 deaths per day. Lung ...

A new report from the American Cancer Society shows 7 in 10 cancer patients are living at least 5 years post-diagnosis.